Literature DB >> 24132635

Going with the flow: from circulating tumor cells to DNA.

Francois-Clement Bidard1, Britta Weigelt, Jorge S Reis-Filho.   

Abstract

Molecular analyses of circulating tumor DNA (ctDNA) in plasma from cancer patients have the potential to deliver minimally invasive diagnostic and disease-monitoring biomarkers. Drawing from experience gained through the translation of circulating tumor cell detection to clinical tests, we discuss ctDNA as a source of tumor material for biomarker development.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24132635     DOI： 10.1126/scitranslmed.3006305

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  49 in total

Review 1.  Nano-plasmonic exosome diagnostics.

Authors:  Hyungsoon Im; Huilin Shao; Ralph Weissleder; Cesar M Castro; Hakho Lee
Journal:  Expert Rev Mol Diagn       Date:  2015-05-02       Impact factor: 5.225

2.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

Authors:  Peiyong Jiang; Carol W M Chan; K C Allen Chan; Suk Hang Cheng; John Wong; Vincent Wai-Sun Wong; Grace L H Wong; Stephen L Chan; Tony S K Mok; Henry L Y Chan; Paul B S Lai; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 3.  Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.

Authors:  Kristofor Yap; Evan N Cohen; James M Reuben; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

4.  Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.

Authors:  John A Martignetti; Olga Camacho-Vanegas; Nolan Priedigkeit; Catalina Camacho; Elena Pereira; Li Lin; Leopold Garnar-Wortzel; Dagny Miller; Bojan Losic; Hardik Shah; Jun Liao; Jian Ma; Pratik Lahiri; Mark Chee; Eric Schadt; Peter Dottino
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 5.  New challenges in perioperative management of pancreatic cancer.

Authors:  Francesco Puleo; Raphaël Maréchal; Pieter Demetter; Maria-Antonietta Bali; Annabelle Calomme; Jean Closset; Jean-Baptiste Bachet; Jacques Deviere; Jean-Luc Van Laethem
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

6.  Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.

Authors:  Fang Wei; Chien-Chung Lin; Aron Joon; Ziding Feng; Gabriel Troche; Maruja E Lira; David Chia; Mao Mao; Chung-Liang Ho; Wu-Chou Su; David T W Wong
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

Review 7.  Genomic approaches to accelerate cancer interception.

Authors:  Jennifer Beane; Joshua D Campbell; Julian Lel; Jessica Vick; Avrum Spira
Journal:  Lancet Oncol       Date:  2017-07-26       Impact factor: 41.316

Review 8.  Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.

Authors:  Camila D M Campos; Joshua M Jackson; Małgorzata A Witek; Steven A Soper
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

Review 9.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

10.  Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).

Authors:  Chris Karlovich; Jonathan W Goldman; Jong-Mu Sun; Elaina Mann; Lecia V Sequist; Krzysztof Konopa; Wei Wen; Philipp Angenendt; Leora Horn; David Spigel; Jean-Charles Soria; Benjamin Solomon; D Ross Camidge; Shirish Gadgeel; Cloud Paweletz; Lin Wu; Sean Chien; Patrick O'Donnell; Shannon Matheny; Darrin Despain; Lindsey Rolfe; Mitch Raponi; Andrew R Allen; Keunchil Park; Heather Wakelee
Journal:  Clin Cancer Res       Date:  2016-01-08       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.